UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Excluding whole grain-containing foods from the Nova ultraprocessed food category: a cross-sectional analysis of the impact on associations with cardiometabolic risk measures

The American journal of clinical nutrition, 2024-05, Vol.119 (5), p.1133-1142

2024

Volltextzugriff (PDF)

Comparison of Mammographic Findings Following Oncoplastic Mammoplasty and Lumpectomy Without Reconstruction

Annals of surgical oncology, 2016-01, Vol.23 (1), p.65-71

2016

Volltextzugriff (PDF)

Exploration of PET and MRI radiomic features for decoding breast cancer phenotypes and prognosis

NPJ breast cancer, 2018-08, Vol.4 (1), p.24-13, Article 24

2018

Volltextzugriff (PDF)

Diffusion-Weighted MRI for Predicting Pathologic Complete Response in Neoadjuvant Immunotherapy

Cancers, 2022-09, Vol.14 (18), p.4436

2022

Volltextzugriff (PDF)

The Predicament of the Probably Benign Breast MRI: Should We Rely on Intuition?

The breast journal, 2017-09, Vol.23 (5), p.501-503

2017

Volltextzugriff (PDF)

Use of the probably benign (BI‐RADS category 3) assessment for masses on breast MRI: Is it transferable to general clinical practice?

The breast journal, 2018-03, Vol.24 (2), p.109-114

2018

Volltextzugriff (PDF)

Magnetic Resonance Imaging–Guided Biopsy of the Breast

Magnetic resonance imaging clinics of North America, 2013-08, Vol.21 (3), p.571-581

Price, Elissa R

2013

Volltextzugriff (PDF)

Impact of Breast Density Legislation on Breast Cancer Risk Assessment and Supplemental Screening: A Survey of 110 Radiology Facilities

The breast journal, 2016-09, Vol.22 (5), p.493-500

2016

Volltextzugriff (PDF)

How to use magnetic resonance imaging following neoadjuvant chemotherapy in locally advanced breast cancer

World journal of clinical cases, 2015-07, Vol.3 (7), p.607-613

2015

Volltextzugriff (PDF)

Mammographic Changes After Oncoplastic Reduction Mammoplasty

Annals of plastic surgery, 2015-02, Vol.Publish Ahead of Print

2015

Volltextzugriff (PDF)

Breast Metastasis from Testicular Leiomyosarcoma

The breast journal, 2013-05, Vol.19 (3), p.336-337

2013

Volltextzugriff (PDF)

Abstract P3-03-07: Single-institution retrospective analysis of lymph node (LN) change on breast MRI in patients with high risk early-stage breast cancer receiving neoadjuvant chemotherapy with and without immunotherapy on the ISPY-2 TRIAL

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.P3-P3-03-07

2022

Volltextzugriff (PDF)

No wonder everyone is confused - food guidance systems are not always consistent with dietary guidelines

Annals of nutrition and metabolism, 2023-08, Vol.79, p.423

2023

Volltextzugriff (PDF)

Abstract P3-03-08: Background parenchymal enhancement as an imaging biomarker in neoadjuvant endocrine therapy for DCIS

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.P3-P3-03-08

2022

Volltextzugriff (PDF)

Abstract PS3-02: Radiologic review to refine selection of candidates for de-escalation of neoadjuvant therapy

Cancer research (Chicago, Ill.), 2021-02, Vol.81 (4_Supplement), p.PS3-02-PS3-02

2021

Volltextzugriff (PDF)

Abstract PS3-14: Assessment of clip locations on breast MRI during NAC to guide tumor bed biopsy at mid-treatment

Cancer research (Chicago, Ill.), 2021-02, Vol.81 (4_Supplement), p.PS3-14-PS3-14

2021

Volltextzugriff (PDF)

Regional lymph node changes on breast MRI in patients with early-stage breast cancer receiving neoadjuvant chemo-immunotherapy

Breast cancer research and treatment, 2024-09

2024

Volltextzugriff (PDF)

Abstract P3-03-02: Diffusion-weighted MRI for prediction of pathologic complete response in HER2- breast cancer treated with pembrolizumab plus neoadjuvant chemotherapy

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.P3-P3-03-02

2022

Volltextzugriff (PDF)

Abstract P3-03-01: Functional tumor volume at 3 and 6-week MRI as an indicator of patients with inferior outcome after neoadjuvant chemotherapy

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.P3-P3-03-01

2022

Volltextzugriff (PDF)

Phase II Single-Arm Study of Preoperative Letrozole for Estrogen Receptor-Positive Postmenopausal Ductal Carcinoma In Situ: CALGB 40903 (Alliance)

Journal of clinical oncology, 2020-04, Vol.38 (12), p.1284-1292

2020

Volltextzugriff (PDF)

Abstract PD6-05: Subtype-specific MRI models to guide selection of candidates for de-escalation of neoadjuvant therapy

Cancer research (Chicago, Ill.), 2021-02, Vol.81 (4_Supplement), p.PD6-05-PD6-05

2021

Volltextzugriff (PDF)

Datopotamab-deruxtecan plus durvalumab in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial

Nature medicine, 2024-09

2024

Volltextzugriff (PDF)

Datopotamab-deruxtecan in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial

Nature medicine, 2024-09

2024

Volltextzugriff (PDF)

Abstract P3-01-04: Mammographic changes after oncoplastic reduction mammoplasty

Cancer research (Chicago, Ill.), 2015-05, Vol.75 (9_Supplement), p.P3-P3-01-04

2015

Volltextzugriff (PDF)

Breast Density Notification Legislation: Pros and Cons of a New Paradigm

Breast diseases, 2014, Vol.25 (3), p.201-203

Price, Elissa R.

2014

Volltextzugriff (PDF)

1 – 25 von 66

Suche als RSS-Feed

Aktive Filter

KollektionCambridge Journals Online (DEFF)

ThemaRadiology, Nuclear Medicine & Medical Imaging

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(64)
Mit Volltextzugriff
(60)

Publikationsform

Artikel
(66)

Sprache

Englisch
(66)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Excluding whole grain-containing foods from the Nova ultraprocessed food category: a cross-sectional analysis of the impact on associations with cardiometabolic risk measures

Comparison of Mammographic Findings Following Oncoplastic Mammoplasty and Lumpectomy Without Reconstruction

Exploration of PET and MRI radiomic features for decoding breast cancer phenotypes and prognosis

Diffusion-Weighted MRI for Predicting Pathologic Complete Response in Neoadjuvant Immunotherapy

The Predicament of the Probably Benign Breast MRI: Should We Rely on Intuition?

Use of the probably benign (BI‐RADS category 3) assessment for masses on breast MRI: Is it transferable to general clinical practice?

Magnetic Resonance Imaging–Guided Biopsy of the Breast

Impact of Breast Density Legislation on Breast Cancer Risk Assessment and Supplemental Screening: A Survey of 110 Radiology Facilities

How to use magnetic resonance imaging following neoadjuvant chemotherapy in locally advanced breast cancer

Mammographic Changes After Oncoplastic Reduction Mammoplasty

Breast Metastasis from Testicular Leiomyosarcoma

Abstract P3-03-07: Single-institution retrospective analysis of lymph node (LN) change on breast MRI in patients with high risk early-stage breast cancer receiving neoadjuvant chemotherapy with and without immunotherapy on the ISPY-2 TRIAL

No wonder everyone is confused - food guidance systems are not always consistent with dietary guidelines

Abstract P3-03-08: Background parenchymal enhancement as an imaging biomarker in neoadjuvant endocrine therapy for DCIS

Abstract PS3-02: Radiologic review to refine selection of candidates for de-escalation of neoadjuvant therapy

Abstract PS3-14: Assessment of clip locations on breast MRI during NAC to guide tumor bed biopsy at mid-treatment

Regional lymph node changes on breast MRI in patients with early-stage breast cancer receiving neoadjuvant chemo-immunotherapy

Abstract P3-03-02: Diffusion-weighted MRI for prediction of pathologic complete response in HER2- breast cancer treated with pembrolizumab plus neoadjuvant chemotherapy

Abstract P3-03-01: Functional tumor volume at 3 and 6-week MRI as an indicator of patients with inferior outcome after neoadjuvant chemotherapy

Phase II Single-Arm Study of Preoperative Letrozole for Estrogen Receptor-Positive Postmenopausal Ductal Carcinoma In Situ: CALGB 40903 (Alliance)

Abstract PD6-05: Subtype-specific MRI models to guide selection of candidates for de-escalation of neoadjuvant therapy

Datopotamab-deruxtecan plus durvalumab in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial

Datopotamab-deruxtecan in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial

Abstract P3-01-04: Mammographic changes after oncoplastic reduction mammoplasty

Breast Density Notification Legislation: Pros and Cons of a New Paradigm

Aktive Filter

Suchergebnisse filtern